What is the Buying Price of Caplin Point Laboratories Share?

The Buying Price of Caplin Point Laboratories share is 1988.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

How to buy Caplin Point Laboratories Share at Choice?

To buy Caplin Point Laboratories stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Caplin Point Laboratories, choose your preferred order type, and place the trade.

What is the PE ratio of Caplin Point Laboratories Shares?

The Price-to-earnings (P/E) ratio of Caplin Point Laboratories shares is 23.66. You can compare it with the sector average for relative valuation.

What is the PB ratio of Caplin Point Laboratories Shares?

The Price to Book (P/B) ratio Caplin Point Laboratories shares is 4.23. Useful to assess the stock's value relative to its book value.

Is Caplin Point Laboratories Overvalued?

To assess Caplin Point Laboratories’s valuation compare Sector P/E, P/B which are 69.94 & 2.97 with sector averages, along with growth rates and financial metrics.

What is the Market Cap of Caplin Point Laboratories?

The Market Cap of Caplin Point Laboratories is 15111.89 CR. It indicates the company's size category and trading liquidity.

What is the 52 Week High and Low of Caplin Point Laboratories Share Price?

The 52 week high and low prices of Caplin Point Laboratories share price is 2395 & 1500.3. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Which sector does Caplin Point Laboratories belong to?

Caplin Point Laboratories belongs to the Healthcare sector.

Caplin Point Laboratories Share price

CAPLIPOINT

Healthcare Large Cap

1988.1

10.80 (-0.54%)

NSE

BSE

Last updated on 2 Jun, 2026 | 15:31 IST

BUYSELL

Today's High

2007.80

Today's Low

1962.70

52 Week Low

1500.30

52 Week High

2395.00

Free Demat with Zero AMC*

Caplin Point Laboratories Chart

ChartIQ

TradingView

Caplin Point Laboratories Share Key Metrics

Volume

75756.00

Market Cap

15111.89 CR

LTQ@LTP

1@1988.10

ATP

1981.28

Var Margin

18.22 %

Circuit Range

1599.2-2398.6

Delivery %

57.24 %

Value

15.01 CR

ASM/GSM

No

Market Lot

1

Summary

2 Jun, 2026 | 15:31 को, Caplin Point Laboratories का शेयर प्राइस आज ₹1988.1 पर है, जो दिन के लिए 10.80% की -0.54 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹1962.70 और ₹2007.80 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹1500.30 से ₹2395.00 तक रही है। ट्रेडिंग गतिविधि के मामले में, Caplin Point Laboratories ने 75756 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹76011696 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹198128 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 1,198810 रही। यह स्टॉक ₹1599.2-2398.6 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹15.01 CR है। दिन के लिए डिलीवरी परसेंटेज 57.24% रही। इसके अतिरिक्त, Caplin Point Laboratories वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Caplin Point Laboratories Fundamentals

P/E Ratio

23.66

P/B Ratio

4.23

Div. Yield

0.2

Sector P/E

69.94

Sector P/B

2.97

Sec. Div. Yield

0.55

Caplin Point Laboratories Resistance and Support

Pivot 2020.6

Resistance

First Resistance

2051.2

Second Resistance

2103.5

Third Resistance

2134.1

Support

First Support

1968.3

Second Support

1937.7

Third Support

1885.4

Caplin Point Laboratories Shareholding Pattern

2016-17
2018-19
2019-20
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

70.57%

Mutual Fund

2.02%

Insurance

0.01%

Foreign Institutional Investors

6.15%

Domestic Institutional Investors

0.11%

Retail

21.14%

Others

0%

Total Promoters

MAR '26

70.57%

Caplin Point Laboratories Corporate Actions

Date	Agenda
2026-05-14	Audited Results & Interim Dividend
2026-02-05	Quarterly Results

Caplin Point Laboratories News

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Caplin Point Laboratories will attend the 16th Annual Global Investor Conference, 'TRINITY INDIA 2026', on May 28, 2026, in Mumbai. The company will engage with various analysts and institutional investors through one-on-one and group meetings.

May 22 2026 18:18:38

Caplin Point Laboratories Limited

Caplin Steriles, a subsidiary of Caplin Point Laboratories, secured final USFDA approval for its Foscarnet Sodium Injection ANDA. This approval allows the company to launch a generic version of a drug with US sales of approximately $15 million.

May 14 2026 19:09:20

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Caplin Point Laboratories' subsidiary, Caplin Steriles Limited, secured USFDA final approval for Foscarnet Sodium Injection (6000 mg/250 mL), a generic antiviral drug. This approval opens up access to the US market for a product with approximately $15 million in annual sales.

May 14 2026 19:00:12

Caplin Point Laboratories Limited

Caplin Point declared an interim dividend of Rs. 4 per equity share for FY26. The record date is May 30, 2026, and payment will be made by June 13, 2026.

May 14 2026 18:46:05

Caplin Point Laboratories Ltd - 524742 - Corporate Action-Board approves Dividend

Caplin Point declared an interim dividend of ₹4.00 per equity share (200% on ₹2 face value) for FY26. The record date for eligibility is May 30, 2026, impacting shareholders for the fiscal year ending March 31, 2026.

May 14 2026 13:28:25

Caplin Point Laboratories Ltd - 524742 - Board Meeting Outcome for For Meeting Held On May 14, 2026

Caplin Point Laboratories board declared an interim dividend of ₹4.00 per share and approved Q4 and FY26 consolidated results. For Q4 FY26, total revenue rose 19% YoY to ₹628.52 cr, and net profit increased 19% YoY to ₹172.88 cr. The full-year FY26 saw total revenue grow 13.2% YoY to ₹2,302.73 cr and net profit rise 20.1% YoY to ₹649.73 cr, with a record date for dividend set for May 30, 2026.

May 14 2026 13:16:43

Caplin Point Laboratories Limited

Caplin Point Laboratories will hold a board meeting on May 14, 2026. The agenda includes considering annual financial results for FY26 and the declaration of an interim dividend, if any, along with fixing its record date.

May 07 2026 16:24:47

Caplin Point Laboratories Limited

CAPLIN POINT LABORATORIES LIMITED board will convene on May 14, 2026, to review and approve the audited annual standalone and consolidated financial results for the financial year ending March 2026. Additionally, the board will consider declaring an interim dividend for shareholders.

May 07 2026 16:17:32

Caplin Point Laboratories Ltd - 524742 - Board Meeting Intimation for Approval Of Financial Results And Declaration Of Interim Dividend, If Any, Approved By The Board.

Caplin Point Laboratories has scheduled a board meeting for May 14, 2026. The agenda includes the consideration and approval of the annual audited financial results for FY2025-26 and the potential declaration of an interim dividend, along with fixing its record date.

May 07 2026 16:06:35

Caplin Point Laboratories Limited

Caplin Point's subsidiary, Caplin Steriles Limited, has received final USFDA approval for its Abbreviated New Drug Application (ANDA) for Calcium Gluconate Injection USP. This approval opens access to the US market for a drug with annual sales of approximately $71 million.

May 05 2026 12:43:13

Name	Position
G Venkatram	General Counsel & Company Secretary, Compliance Officer
C C Paarthipan	Chairman

Caplin Point Laboratories Similar Stocks

Granules India Ltd.

777.55

-1.45 (0.19%)

Astrazeneca Pharma India Ltd.

8710.00

-19.00 (0.22%)

Natco Pharma Ltd.

939.30

6.00 (0.64%)

Cohance Lifesciences Ltd.

428.90

-0.50 (0.12%)

Jubilant Pharmova Ltd.

975.05

-12.50 (1.27%)

Dr. Agarwal's Health Care Ltd.

476.55

-4.80 (1.00%)

Alembic Pharmaceuticals Ltd.

725.50

5.50 (0.76%)

Rainbow Children's Medicare Ltd.

1341.40

-28.20 (2.06%)

Poly Medicure Ltd.

1321.40

-12.50 (0.94%)

Vijaya Diagnostic Centre Ltd.

1317.00

76.10 (6.13%)

Caplin Point Laboratories FAQs

Caplin Point Laboratories शेयर का खरीद मूल्य 1988.1 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Caplin Point Laboratories शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Caplin Point Laboratories शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 23.66 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Caplin Point Laboratories शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 4.23 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Caplin Point Laboratories शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 2.97 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Caplin Point Laboratories का मार्केट कैप 15111.89 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Caplin Point Laboratories शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 2395.00 और 1500.30 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।